Epicrispr Biotechnologies Announces Five Presentations Highlighting Advances in Epigenetic Modulation and AAV Manufacturing at ASGCT 2025 Annual Meeting

– Preclinical data showcase scalable AAV manufacturing, compact gene activators, and expanded Cas effector tools for precise epigenetic modulation SAN FRANCISCO–(BUSINESS WIRE)– Epicrispr Biotechnologies, a biotechnology company focused on developing curative therapies, today announced five presentations at the upcoming American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting, being held May 15-17, 2025, … Read more